famotidine has been researched along with Histiocytoma, Benign Fibrous in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Histiocytoma, Benign Fibrous: A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Torralba, M | 1 |
| MartÃnez, A | 1 |
| Puras, A | 1 |
1 other study available for famotidine and Histiocytoma, Benign Fibrous
| Article | Year |
|---|---|
[Leukocytoclastic vasculitis and leiomyosarcoma].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Famotidine; Foot Diseases; Histiocytoma, Benign Fibrous; Hu | 1993 |